COVID-19 affects the lungs first and then spreads throughout the body. The worst prognoses are typically seen in ‘at-risk’ categories, such as the immunocompromised, old, or those suffering from respiratory diseases.

At first look, smokers appear to be more prone to get the disease than nonsmokers, owing to higher levels of respiratory disease, a higher likelihood of taking immune-suppressing medicines for cancer treatment, and already damaged lungs.

Early data appeared to confirm this, with smokers in China being overrepresented among severe COVID-19 cases. However, insufficient data was extracted on moderate and asymptomatic cases, and more recent research have yielded contradictory results, even implying that smoking may offer some protection against getting the disease.

Indiana University researchers have been examining transmission to persons who take nicotine in various ways, as well as self-reported health state. Their findings have been published in the journal BMC Public Health.

The researchers used data from two state-wide testing operations that took place as part of seroprevalence studies in April and June 2020. Participants were evaluated for active infection as well as antibodies against SARS-COV-2. Participants in each study were chosen at random from tax records, and then a non-random group of racial and ethnic minorities were included to reduce under-representation in testing attempts.

All participants were asked to provide information about their demographics, health status, and primary nicotine and cigarette habits. Tobacco habits were divided into three categories: cigarettes, chewing tobacco, and vaping, and participants were asked if they smoked every day, some days, or not at all.

Testing for the presence of active SARS-CoV-2 was conducted with nasopharyngeal swabs and RT-PCR, while 2-3mL of blood was examined for antibody presence with a chemiluminescent microparticle immunoassay. Data from both waves were merged and evaluated using a bivariate logistic regression model that controlled for age, gender, ethnicity, random/non-random status, and nicotine consumption.

A total of 8,214 people were interviewed, with over 1,300 of them being active smokers. 11 percent smoked cigarettes every day, whereas 3 percent smoked cigarettes occasionally. Chewing tobacco was less prevalent, accounting for 1.4 percent and 0.9 percent, respectively. Vaping produced comparable outcomes, with 1.3 percent everyday and 1.5 percent on some days. In terms of self-reported health, 16percent described themselves as ‘excellent,’ 38percent as’very good,’ and 35percent as ‘good.’

The researchers discovered that those who smoked cigarettes on a daily basis were more likely to be protected from COVID-19, with lower present and prior infection than nonsmokers. Vaping/e-cigarettes had no association with infection, however, chewing tobacco had a positive association.

Previous research indicating lower transmission rates to smokers support these findings. Those who reported their health as ‘excellent’ had lower positive rates than those who reported their health as ‘good’ or ‘fair.’

The scientists believe that the lower risk of transmission that daily smoking is related to nicotine’s proclivity to connect with the angiotensin-converting enzyme 2 (ACE2) receptor. This receptor is an important target for SARS-CoV-2; the spike protein’s S1 subunit has a receptor-binding region that binds to ACE2 to allow viral cell entrance.

As a result, nicotine may bind to them, limiting the amount of SARS-CoV-2 sites available and avoiding infection. However, smokers who have already had more severe respiratory disorders are at a significantly higher risk of contracting COVID-19, which is why the initial research from China reported exaggerated estimates of smokers suffering from COVID-19 who required hospitalization.

The authors stress that their study did not include hospitalized people, which eliminates the bias found in many other studies that found smokers to be at increased risk. However, the authors point out that the lower transmission risk shown in their study is only valid for silent and slightly symptomatic coronavirus infections.

Electronic/vaping equipment has grown in popularity in recent years in Indiana, where smoking rates are greater than in the rest of the country. These findings could be critical in defining public health policies. To effectively target restrictions and prevent the spread of COVID-19 to those most vulnerable, lawmakers and public health officials must first understand the factors that influence transmission, as well as the likelihood that COVID-19 will progress to more severe prognoses that may require inpatient care.

With the growing threat of dangerous variants like the Delta strain, this information is more vital than ever.

Image Credit: Getty

You were reading: People who consume this daily may have a lower risk of developing SARS-CoV-2 infection